Prescribing e-cigarettes can be helpful even for the most stubborn of smokers, as demonstrated by a pilot program involving 300 people who smoke more than a pack a day. They received a £25 voucher to use at stores that sell e-cigarette products, and also stayed in regular contact with experts who helped them properly combat smoking.
Within one month, 40% of those who used the discount coupons claimed to have quit smoking permanently. Although the final cessation rate dropped to 15% after three months, with many individuals resuming smoking, researchers believe that even this figure represents a significant success. Now, they plan to expand the pilot program to include 750,000 adult citizens.
According to researchers, the initial results are very positive and should be promoted nationwide. General practitioners should prescribe e-cigarettes to those who want to quit smoking. However, some scientists are concerned that e-cigarettes may pose health risks to humans as they increase the risk of cancer and lung disease, albeit to a different degree than traditional cigarettes.
Statement
This article is compiled from third-party information and is intended for industry professionals to exchange and learn from.
This article does not represent the views of 2FIRSTS, and 2FIRSTS cannot confirm the accuracy or truthfulness of the article's content. The translation of this article is intended only for industry exchange and research purposes.
Due to limitations in translation ability, the translated article may not fully express the original content. Please refer to the original article for accuracy.
2FIRSTS maintains complete alignment with the Chinese government in regards to any domestic, Hong Kong, Macau, Taiwan, and foreign-related statements and positions.
The copyright of compiled information belongs to the original media and authors. If there is any infringement, please contact us for deletion.
Disclaimer
This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.
Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.
The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.
This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.
Copyright Notice
This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.
No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.
For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.
AI-Assisted Translation and Editing Notice
Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.
Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.
